Human medicines European public assessment report (EPAR): Simbrinza, brinzolamide / brimonidine tartrate, Ocular Hypertension,Glaucoma, Open-Angle, Date of authorisation: 18/07/2014, Revision: 6, Status: Authorised

Case Medical Research ◽

10.31525/cmr-cdebcb ◽

2019 ◽

Author(s):

Keyword(s):

Ocular Hypertension ◽

Open Angle ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Brimonidine Tartrate

Download Full-text

Human medicines European public assessment report (EPAR): Simbrinza, brinzolamide / brimonidine tartrate, Ocular Hypertension,Glaucoma, Open-Angle, Date of authorisation: 18/07/2014, Revision: 6, Status: Authorised

Case Medical Research ◽

10.31525/cmr-cd9d67 ◽

2019 ◽

Author(s):

Keyword(s):

Ocular Hypertension ◽

Open Angle ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Brimonidine Tartrate

Download Full-text

Human medicines European public assessment report (EPAR): Lumigan, bimatoprost, Glaucoma, Open-Angle,Ocular Hypertension, Date of authorisation: 08/03/2002, Revision: 31, Status: Authorised

Case Medical Research ◽

10.31525/cmr-39970e ◽

2019 ◽

Author(s):

Keyword(s):

Ocular Hypertension ◽

Open Angle ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Izba, travoprost, Ocular Hypertension,Glaucoma, Open-Angle, Date of authorisation: 20/02/2014, Revision: 4, Status: Authorised

Case Medical Research ◽

10.31525/cmr-189165f ◽

2019 ◽

Author(s):

Keyword(s):

Ocular Hypertension ◽

Open Angle ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): DuoTrav, travoprost / timolol, Glaucoma, Open-Angle,Ocular Hypertension, Date of authorisation: 23/04/2006, Revision: 16, Status: Authorised

Case Medical Research ◽

10.31525/cmr-587198 ◽

2018 ◽

Author(s):

Keyword(s):

Ocular Hypertension ◽

Open Angle ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Ganfort, bimatoprost / timolol, Glaucoma, Open-Angle,Ocular Hypertension, Date of authorisation: 19/05/2006, Revision: 17, Status: Authorised

Case Medical Research ◽

10.31525/cmr-a9b0ba ◽

2019 ◽

Author(s):

Keyword(s):

Ocular Hypertension ◽

Open Angle ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): DuoTrav, travoprost / timolol, Glaucoma, Open-Angle,Ocular Hypertension, Date of authorisation: 23/04/2006, Revision: 16, Status: Authorised

Case Medical Research ◽

10.31525/cmr-57f5b1 ◽

2018 ◽

Author(s):

Keyword(s):

Ocular Hypertension ◽

Open Angle ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Rhokiinsa, netarsudil, Glaucoma, Open-Angle,Ocular Hypertension, Date of authorisation: 19/11/2019, Status: Authorised

Case Medical Research ◽

10.31525/cmr-235be0f ◽

2019 ◽

Author(s):

Keyword(s):

Ocular Hypertension ◽

Open Angle ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Ganfort, bimatoprost / timolol, Glaucoma, Open-Angle,Ocular Hypertension, Date of authorisation: 19/05/2006, Revision: 17, Status: Authorised

Case Medical Research ◽

10.31525/cmr-a9af14 ◽

2019 ◽

Author(s):

Keyword(s):

Ocular Hypertension ◽

Open Angle ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Lumigan, bimatoprost, Glaucoma, Open-Angle,Ocular Hypertension, Date of authorisation: 08/03/2002, Revision: 31, Status: Authorised

Case Medical Research ◽

10.31525/cmr-ce82ec ◽

2019 ◽

Author(s):

Keyword(s):

Ocular Hypertension ◽

Open Angle ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Rhokiinsa, netarsudil, Glaucoma, Open-Angle,Ocular Hypertension, Date of authorisation: 19/11/2019, Status: Authorised

Case Medical Research ◽

10.31525/cmr-235c45b ◽

2019 ◽

Author(s):

Keyword(s):

Ocular Hypertension ◽

Open Angle ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text